Anti-Cytochrome P450 4A antibody (ab3573)

ab3573 has been referenced in 7 publications.

• Drolet B  et al. Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes-A Link in the Onset and Development of Cardiovascular Disease? Pharmaceutics 9:N/A (2017). PubMed: 29023376
• Zhu J  et al. Additive Neuroprotection of a 20-HETE Inhibitor with Delayed Therapeutic Hypothermia after Hypoxia-Ischemia in Neonatal Piglets. Dev Neurosci 37:376-89 (2015). PubMed: 25721266
• Zhang Y  et al. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition. Am J Physiol Regul Integr Comp Physiol 307:R693-703 (2014). WB ; Mouse . PubMed: 24990856
• Rector RS  et al. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300:G874-83 (2011). WB ; Rat . PubMed: 21350190
• Zhao X & Li LY PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats. Am J Nephrol 28:598-606 (2008). WB ; Rat . PubMed: 18277067
• Theve EJ  et al. Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus. Infect Immun 76:4071-8 (2008). PubMed: 18559427
• McCarthy ET  et al. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int 67:152-6 (2005). PubMed: 15610238